Roche Holding Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AAPL | Apple | Outperform |
16
|
$169.02 | $200.65 | 18.33% | 12 | $2.58T |
| LLY | Eli Lilly and | Outperform |
16
|
$732.20 | $636.99 | 14.38% | 9 | $654.24B |
| AVGO | Broadcom | Outperform |
8
|
$1.26k | $1.21k | 23.33% | 11 | $558.29B |
| ABBV | AbbVie | Outperform |
9
|
$167.80 | $178.42 | 12.63% | 11 | $294.65B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£113.52 | £165.99 | 42.55% | 16 | £169.69B |
| ABT | Abbott Laboratories | Outperform |
9
|
$106.89 | $118.92 | 18.35% | 7 | $186.15B |
| DHR | Danaher | Outperform |
10
|
$250.41 | $260.33 | 7.82% | 4 | $187.44B |
| GE | General Electric | Outperform |
8
|
$159.19 | $144.00 | 8.99% | 3 | $177.79B |
| AMGN | Amgen | Outperform |
4
|
$273.01 | $303.65 | 16.20% | 8 | $144.25B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$48.86 | $58.15 | 12.57% | 10 | $99.17B |
| BSX | Boston Scientific | Outperform |
11
|
$72.91 | $70.14 | 0.12% | 6 | $98.97B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$67.08 | $87.82 | 19.26% | 14 | $83.25B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$233.83 | $284.47 | 19.75% | 8 | $67.64B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥4.73k | ¥5.24k | 22.65% | 0 | ¥8.89T |
| 4519 | Chugai Pharmaceutical | Outperform |
6
|
¥5.15k | ¥4.92k | 19.39% | 0 | ¥8.10T |
| MMM | 3M | Hold |
10
|
$92.02 | $109.39 | 8.67% | 3 | $51.06B |
| DXCM | DexCom Inc | Buy |
12
|
$137.87 | $125.98 | 8.80% | 2 | $50.39B |
| ALC | Alcon | Outperform |
8
|
CHF72.80 | CHF90.64 | 32.36% | 3 | CHF35.75B |
| A | Agilent Technologies | Outperform |
10
|
$137.49 | $138.82 | 10.19% | 10 | $38.90B |
| CTVA | Corteva | Outperform |
12
|
$54.77 | $61.72 | 16.85% | 1 | $38.30B |
| DD | DuPont de Nemours | Outperform |
17
|
$73.96 | $75.38 | 8.17% | 14 | $30.89B |
| BIIB | Biogen | Outperform |
10
|
$201.99 | $299.62 | 44.56% | 13 | $28.26B |
| BAYN | Bayer | Hold |
5
|
26.97€ | 45.15€ | 18.65% | 4 | 25.86€B |
| 7751 | Canon | Hold |
18
|
¥4.28k | ¥3.74k | -11.24% | 0 | ¥3.69T |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.01k | kr2.71k | 27.74% | 14 | kr130.39B |
| CE | Celanese | Hold |
13
|
$156.05 | $148.23 | 2.53% | 18 | $17.23B |
| BGNE | BeiGene | Buy |
6
|
$138.99 | $285.19 | 97.86% | 2 | $13.53B |
| BIM | bioMérieux | Outperform |
18
|
101.40€ | 105.55€ | 12.18% | 1 | 11.76€B |
| ERF | Eurofins Scientific | Hold |
18
|
61.60€ | 0.00€ | -4.22% | 5 | 11.44€B |
| FME | Fresenius Medical Care AG & Co... | Hold |
18
|
39.90€ | 41.13€ | -3.51% | 12 | 10.74€B |
| EXAS | Exact Sciences | Buy |
8
|
$63.53 | $90.32 | 39.48% | 7 | $11.07B |
| 4523 | Eisai | Outperform |
18
|
¥6.09k | ¥9.58k | 37.93% | 0 | ¥1.69T |
| BRKR | Bruker | Outperform |
16
|
$82.46 | $73.64 | 9.75% | 1 | $10.71B |
| TECH | Bio-Techne Corp | Buy |
16
|
$63.69 | $100.78 | 25.61% | 2 | $9.76B |
| BIO | Bio-Rad Laboratories Inc | Buy |
16
|
$285.28 | $536.80 | 53.08% | 1 | $8.76B |
| CRDA | Croda International Plc | Outperform |
18
|
£48.88 | £65.12 | 4.34% | 6 | £6.81B |
| EXEL | Exelixis | Outperform |
16
|
$23.29 | $26.44 | 15.93% | 5 | $6.21B |
| GETI B | Getinge AB | Outperform |
18
|
kr232.10 | kr226.10 | -2.84% | 3 | kr63.03B |
| DIA | DiaSorin S.p.A. | Hold |
18
|
95.86€ | 102.04€ | 4.32% | 1 | 5.17€B |
| BPMC | Blueprint Medicines | Outperform |
6
|
$92.29 | $85.71 | 8.35% | 5 | $5.53B |
| CLN | Clariant | Outperform |
18
|
CHF13.23 | CHF16.11 | 13.38% | 6 | CHF4.33B |
| ALKS | Alkermes | Outperform |
10
|
$24.26 | $33.27 | 40.15% | 3 | $4.04B |
| BIOCON | Biocon | Hold |
14
|
Rp280.15 | Rp270.86 | -5.41% | 14 | Rp312.41B |
| BHC | Bausch Health Companies | Hold |
15
|
$8.53 | $9.50 | 11.37% | 5 | $3.19B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$10.98 | HK$3.96 | -65.03% | 0 | HK$22.17B |
| EKTA B | Elekta AB (publ) | Hold |
18
|
kr76.95 | kr83.00 | 1.36% | 1 | kr28.45B |
| 300676 | BGI Genomics | - |
17
|
¥39.23 | ¥0.00 | -100.00% | 0 | ¥18.44B |
| 002773 | Chengdu Kanghong Pharmaceutica... | Buy |
11
|
¥17.78 | ¥24.00 | -100.00% | 1 | ¥16.01B |
| DCPH | Deciphera Pharmaceuticals | Outperform |
6
|
$14.67 | $23.40 | 67.01% | 4 | $1.29B |
| BCRX | BioCryst Pharmaceuticals | Outperform |
7
|
$4.38 | $14.09 | 139.73% | 2 | $1.19B |
| ADPT | Adaptive Biotechnologies | Outperform |
6
|
$2.58 | $8.67 | 132.56% | 2 | $570.40M |
| DHG | DHG Pharmaceutical Joint Stock | Hold |
18
|
111.80k | 125.44k | 4.29% | 0 | 14.55T |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.18 | $10.86 | 266.97% | 3 | $266.16M |
| ALIM | Alimera Sciences | Buy |
9
|
$3.59 | $7.00 | 122.84% | 3 | $185.33M |
| DBD | Binh Dinh Pharmaceutical and M... | Outperform |
15
|
₫53.40k | ₫62.90k | 8.61% | 1 | ₫4.02T |
| DCL | Cuu Long Pharmaceutical Joint ... | - |
12
|
₫26.00k | ₫0.00 | -100.00% | 0 | ₫1.90T |
| BIOC | GlaxoSmithKline S.A.E | - |
14
|
£31.56 | £0.00 | -100.00% | 0 | £3.30B |
| DMC | Domesco Medical Import - Expor... | - |
0
|
₫56.20k | ₫0.00 | -100.00% | 0 | ₫1.74T |
| BNGO | Bionano Genomics | Outperform |
6
|
$0.79 | $12.33 | 659.49% | 2 | $44.28M |
| AGL | ANGLE | Buy |
8
|
£0.12 | £0.97 | 475.00% | 0 | £32.56M |
| DRIO | DarioHealth | Buy |
6
|
$1.45 | $4.70 | 244.83% | 1 | $34.42M |
| BCART | Biocartis Group NV | Outperform |
7
|
0.29€ | 1.10€ | -100.00% | 0 | 27.24€M |
| AXDX | Accelerate Diagnostics | Buy |
8
|
$0.95 | $5.00 | -100.00% | 1 | $21.49M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
| 542934 | Chandra Bhagat Pharma | - |
0
|
Rp114.85 | Rp0.00 | -100.00% | 0 | Rp866.55M |
| DBT | Ben Tre Pharmaceutical Joint S... | - |
8
|
₫12.60k | ₫0.00 | -100.00% | 0 | ₫207.33B |
| ARYC | Arrayit | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.11M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |